Watch EHC. Know when insiders buy.
One email the day a filing lands. Free.
Work order
52
WATCH · insiders 25, shorts 79
Insiders, 90 days
−$1.2M
net selling · 0 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $12BP/E 19.8DIV YIELD 0.62%FCF YIELD 3.44%REV TTM $6.2B +9.5%NET INCOME $621M +18.8%NET DEBT $1.1B52W 93.83 – 127.18SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.6B | +9.6% | — | — | $153.9M | +8.3% | 1.54 | $282.6M | $220.3M | $62.3M | Aug 7 |
| Q1 2026 · Mar 31 | $1.6B | +9.0% | — | — | $194.5M | +28.4% | 1.93 | $313.1M | $162.4M | $150.7M | May 1 |
| Q4 2025 · Dec 31derived | $1.5B | +9.9% | — | — | $146.1M | +20.8% | 1.43 | $346M | $229.3M | $116.7M | Feb 26 |
| Q3 2025 · Sep 30 | $1.5B | +9.4% | — | — | $126.5M | +16.9% | 1.24 | $270.8M | $187.1M | $83.7M | Feb 26 |
| Q2 2025 · Jun 30 | $1.5B | +12.0% | — | — | $142.1M | +24.5% | 1.39 | $270.2M | $156.9M | $113.3M | Aug 7 |
| Q1 2025 · Mar 31 | $1.5B | +10.6% | — | — | $151.5M | +34.7% | 1.48 | $288.6M | $163.1M | $125.5M | May 1 |
| Q4 2024 · Dec 31derived | $1.4B | +12.7% | — | — | $120.9M | +38.0% | 1.18 | $278.8M | $198.7M | $80.1M | Feb 26 |
| Q3 2024 · Sep 30 | $1.4B | +11.9% | — | — | $108.2M | +26.8% | 1.06 | $267.8M | $147.5M | $120.3M | Feb 26 |
| Q2 2024 · Jun 30 | $1.3B | — | — | — | $114.1M | — | 1.12 | $217.4M | $156.9M | $60.5M | Aug 6 |
| Q1 2024 · Mar 31 | $1.3B | — | — | — | $112.5M | — | 1.10 | $238.8M | $139.4M | $99.4M | May 1 |
| Q4 2023 · Dec 31derived | $1.2B | — | — | — | $87.6M | — | 0.85 | $201M | $222.6M | −$21.6M | Feb 26 |
| Q3 2023 · Sep 30 | $1.2B | — | — | — | $85.3M | — | 0.84 | $215.2M | $146.7M | $68.5M | Nov 1 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $5.9B | — | — | $566.2M | 9.5% | 5.54 | $1.2B | $736.4M | $439.2M | $158M | $71.1M |
| FY2024 · to Dec 31 | $5.4B | — | — | $455.7M | 8.5% | 4.46 | $1B | $642.5M | $360.3M | $31.1M | $62.8M |
| FY2023 · to Dec 31 | $4.8B | — | — | $352M | 7.3% | 3.47 | $850.8M | $583.1M | $267.7M | $0 | $60.4M |
| FY2022 · to Dec 31 | $4.3B | — | $539.5M | $271M | 6.2% | 2.70 | $705.8M | $564.8M | $141M | $0 | $99M |
| FY2021 · to Dec 31 | $4B | — | $559.6M | $412.2M | 10.3% | 4.11 | $715.8M | $524.6M | $191.2M | $0 | $112.2M |
| FY2020 · to Dec 31 | $3.6B | — | $563.9M | $284.2M | 8.0% | 2.85 | $704.7M | $392.8M | $311.9M | $6.1M | $111.8M |
Every number comes from Encompass Health Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.